COVIDomics: Metabolomic Views on COVID-19
2024
COVIDomics: Metabolomic Views on COVID-19
Editorial
Author Information
Author(s): Cevenini Armando, Santorelli Lucia, Costanzo Michele
Primary Institution: Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II
Conclusion
Metabolomics provides insights into metabolic changes in COVID-19 patients, highlighting potential therapeutic targets and the need for standardized methodologies.
Supporting Evidence
- Metabolomics reveals significant metabolic shifts in COVID-19 patients, especially those with severe disease.
- Liquid biopsy is highlighted as a promising method for monitoring disease markers.
- Research articles included in this Special Issue focus on the impact of SARS-CoV-2 on human metabolism.
Takeaway
Scientists are studying how COVID-19 changes the body's chemistry to find better ways to treat the disease and understand its effects.
Methodology
The article discusses various omics-based methodologies, particularly metabolomics, used to study COVID-19.
Limitations
Methodological inconsistencies across studies highlight the need for standardization in metabolomics.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website